{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:14:18Z","timestamp":1780078458475,"version":"3.54.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Results of a literature review to identify indicators of inappropriate opioid prescribing are presented.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>While prescription opioids can be effective for the treatment of acute pain, inappropriate prescribing practices can increase the risk of opioid-related harms, including overdose and mortality. To date, little research has been conducted to determine how best to define inappropriate opioid prescribing. Five electronic databases were searched to identify studies (published from database inception to January 2017) that defined inappropriate opioid prescribing practices. Search terms varied slightly across databases but included opioid, analgesics, inappropriate prescribing, practice patterns, and prescription drug misuse. Gray literature and references of published literature reviews were manually searched to identify additional relevant articles. From among the 4,665 identified articles, 41 studies were selected for data extraction and analysis. Fourteen studies identified high-daily-dose opioid prescriptions, 14 studies identified coadministration of benzodiazepines and opioids, 10 studies identified inappropriate opioid prescribing in geriatric populations, 8 studies identified other patient-specific factors, 4 studies identified opioid prescribing for the wrong indication, and 4 studies identified factors such as initiation of long-acting opioids in opioid-naive patients as indicators of inappropriate opioid prescribing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A literature review identified various indicators of inappropriate opioid prescribing, including the prescribing of high daily doses of opioids, concurrent benzodiazepine administration, and geriatric-related indicators. Given the significant contribution of inappropriate opioid prescribing to opioid-related harms, identification of these criteria is important to inform and improve opioid prescribing practices among healthcare providers.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ajhp\/zxz092","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T15:32:54Z","timestamp":1561735974000},"page":"1231-1237","source":"Crossref","is-referenced-by-count":21,"title":["Inappropriate opioid prescribing practices: A narrative review"],"prefix":"10.1093","volume":"76","author":[{"given":"Brian","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada, and St. Paul\u2019s Hospital, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada, and British Columbia Centre on Substance Use, St. Paul\u2019s Hospital, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Beaulieu","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, Canada, and Graduate Programs in Rehabilitation Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Shalansky","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Providence Health Care, St. Paul\u2019s Hospital, Vancouver, Canada, and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianping","family":"Ti","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, Canada, and Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"issue":"1","key":"2019080105002838900_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep."},{"issue":"2","key":"2019080105002838900_CIT0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpainsymman.2004.01.003","article-title":"A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002","volume":"28","author":"Gilson","year":"2004","journal-title":"J Pain Symptom Manage."},{"issue":"9","key":"2019080105002838900_CIT0003","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"2019080105002838900_CIT0004","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.17269\/cjph.105.4143","article-title":"Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later","volume":"105","author":"Fischer","year":"2014","journal-title":"Can J Public Health."},{"issue":"2","key":"2019080105002838900_CIT0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2013\/651649","article-title":"Use and nonmedical use of prescription opioid analgesics in the general population of canada and correlations with dispensing levels in 2009","volume":"18","author":"Shield","year":"2013","journal-title":"Pain Res Manag."},{"key":"2019080105002838900_CIT0006","author":"Substance Abuse and Mental Health Services Administration"},{"key":"2019080105002838900_CIT0007","author":"United Nations Office on Drugs and Crime"},{"key":"2019080105002838900_CIT0008","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/pme.12904","article-title":"Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety","volume":"16","author":"Cheatle","year":"2015","journal-title":"Pain Med."},{"key":"2019080105002838900_CIT0009","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician."},{"issue":"8","key":"2019080105002838900_CIT0010","first-page":"648","article-title":"Potential misuse and inappropriate prescription practices involving opioid analgesics","volume":"19","author":"Liu","year":"2013","journal-title":"Am J Manag Care."},{"issue":"8","key":"2019080105002838900_CIT0011","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MLR.0b013e318293c2c0","article-title":"Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse","volume":"51","author":"Logan","year":"2013","journal-title":"Med Care."},{"key":"2019080105002838900_CIT0012","doi-asserted-by":"crossref","first-page":"d5142","DOI":"10.1136\/bmj.d5142","article-title":"Facing up to the prescription opioid crisis","volume":"343","author":"Dhalla","year":"2011","journal-title":"BMJ."},{"issue":"12","key":"2019080105002838900_CIT0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015-2016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"5","key":"2019080105002838900_CIT0014","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/bcp.12446","article-title":"An overview of the patterns of prescription opioid use, costs and related harms in australia","volume":"78","author":"Blanch","year":"2014","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"2019080105002838900_CIT0015","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/bcp.12133","article-title":"Prescription opioid abuse in the UK","volume":"76","author":"Giraudon","year":"2013","journal-title":"Br J Clin Pharmacol."},{"key":"2019080105002838900_CIT0016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2147\/JPR.S131979","article-title":"Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain","volume":"10","author":"Hah","year":"2017","journal-title":"J Pain Res."},{"issue":"13","key":"2019080105002838900_CIT0017","first-page":"1296","article-title":"Nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med."},{"key":"2019080105002838900_CIT0018","author":"Lipari","year":"2013"},{"issue":"4","key":"2019080105002838900_CIT0019","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1185\/03007995.2015.1016607","article-title":"Sources of prescription opioids among diagnosed opioid abusers","volume":"31","author":"Shei","year":"2015","journal-title":"Curr Med Res Opin."},{"issue":"8","key":"2019080105002838900_CIT0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00002512-200522080-00002","article-title":"Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem","volume":"22","author":"Auret","year":"2005","journal-title":"Drugs Aging."},{"issue":"3","key":"2019080105002838900_CIT0021","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jpainsymman.2010.06.006","article-title":"Need for mechanistically focused research of global systemic interventions in palliative care","volume":"40","author":"Abernethy","year":"2010","journal-title":"J Pain Symptom Manage."},{"key":"2019080105002838900_CIT0022","unstructured":"National Academy for State Health Policy. New law to curb opioid abuse and diversion passed in Maine, strengthens prescription drug monitoring program (April 2016). http:\/\/nashp.org\/new-law-to-curb-opioid-abuse-and-diversion-passed-in-maine-strengthens-prescription-drug-monitoring-program\/ (accessed 2017 Jul 9)."},{"issue":"50-51","key":"2019080105002838900_CIT0023","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2019080105002838900_CIT0024","author":"Adams"},{"issue":"4","key":"2019080105002838900_CIT0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajim.21998","article-title":"Bending the prescription opioid dosing and mortality curves: impact of the washington state opioid dosing guideline","volume":"55","author":"Franklin","year":"2012","journal-title":"Am J Ind Med."},{"issue":"18","key":"2019080105002838900_CIT0026","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ."},{"key":"2019080105002838900_CIT0027","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ."},{"issue":"13","key":"2019080105002838900_CIT0028","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA."},{"issue":"2","key":"2019080105002838900_CIT0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Overdose and prescribed opioids: associations among chronic non-cancer pain patients","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med."},{"issue":"5","key":"2019080105002838900_CIT0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","article-title":"High-risk use by patients prescribed opioids for pain and its role in overdose deaths","volume":"174","author":"Gwira Baumblatt","year":"2014","journal-title":"JAMA Intern Med."},{"issue":"1","key":"2019080105002838900_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann Intern Med."},{"issue":"9","key":"2019080105002838900_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns\u2013Prescription Behavior Surveillance System, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"MMWR Surveill Summ."},{"key":"2019080105002838900_CIT0033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsr.2014.09.001","article-title":"Variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012","volume":"51","author":"Paulozzi","year":"2014","journal-title":"J Safety Res."},{"issue":"5","key":"2019080105002838900_CIT0034","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10935-015-0397-0","article-title":"The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances","volume":"36","author":"Ringwalt","year":"2015","journal-title":"J Prim Prev."},{"issue":"11","key":"2019080105002838900_CIT0035","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med."},{"issue":"1","key":"2019080105002838900_CIT0036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1526-4637.2012.01527.x","article-title":"An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners","volume":"14","author":"Holliday","year":"2013","journal-title":"Pain Med."},{"issue":"1","key":"2019080105002838900_CIT0037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpain.2015.10.002","article-title":"The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy","volume":"17","author":"Von Korff","year":"2016","journal-title":"J Pain."},{"issue":"1","key":"2019080105002838900_CIT0038","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med."},{"issue":"6","key":"2019080105002838900_CIT0039","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3122\/jabfm.2011.06.100232","article-title":"Opioids for back pain patients: primary care prescribing patterns and use of services","volume":"24","author":"Deyo","year":"2011","journal-title":"J Am Board Fam Med."},{"issue":"16","key":"2019080105002838900_CIT0040","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1503\/cmaj.120465","article-title":"Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines","volume":"184","author":"Dormuth","year":"2012","journal-title":"CMAJ."},{"issue":"4","key":"2019080105002838900_CIT0041","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med."},{"issue":"4","key":"2019080105002838900_CIT0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1176\/appi.ps.201500116","article-title":"The concentration of opioid prescriptions by providers and among patients in the Oregon Medicaid program","volume":"67","author":"Kim","year":"2016","journal-title":"Psychiatr Serv."},{"issue":"8","key":"2019080105002838900_CIT0043","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pds.3776","article-title":"Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010","volume":"24","author":"Larochelle","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"9","key":"2019080105002838900_CIT0044","first-page":"270","article-title":"Risks associated with co-prescribing opioids and benzodiazepines and Delaware\u2019s prescription drug monitoring program","volume":"87","author":"Parhami","year":"2015","journal-title":"Del Med J."},{"key":"2019080105002838900_CIT0045","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"Bmj."},{"issue":"10","key":"2019080105002838900_CIT0046","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40266-012-0016-1","article-title":"Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria","volume":"29","author":"Dalleur","year":"2012","journal-title":"Drugs Aging."},{"issue":"3","key":"2019080105002838900_CIT0047","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ageing\/afq031","article-title":"Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities","volume":"39","author":"Lang","year":"2010","journal-title":"Age Ageing."},{"issue":"9","key":"2019080105002838900_CIT0048","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40266-013-0097-5","article-title":"Potentially inappropriate prescribing in patients on admission and discharge from an older peoples\u2019 unit of an acute UK hospital","volume":"30","author":"Onatade","year":"2013","journal-title":"Drugs Aging."},{"issue":"6","key":"2019080105002838900_CIT0049","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11096-012-9681-8","article-title":"Inappropriate prescribing in hospitalised australian elderly as determined by the STOPP criteria","volume":"34","author":"Wahab","year":"2012","journal-title":"Int J Clin Pharm."},{"issue":"3","key":"2019080105002838900_CIT0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archinte.164.3.305","article-title":"Inappropriate medication prescribing for elderly ambulatory care patients","volume":"164","author":"Goulding","year":"2004","journal-title":"Arch Intern Med."},{"issue":"2","key":"2019080105002838900_CIT0051","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pds.688","article-title":"Inappropriate prescriptions for the aging population of the United States: an analysis of the national ambulatory medical care survey, 1997","volume":"11","author":"Huang","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"14","key":"2019080105002838900_CIT0052","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2165\/00002512-200421140-00004","article-title":"Potentially inappropriate prescribing in Canada relative to the US","volume":"21","author":"Rochon","year":"2004","journal-title":"Drugs Aging."},{"issue":"23-24","key":"2019080105002838900_CIT0053","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00508-008-1089-z","article-title":"Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria","volume":"120","author":"Schuler","year":"2008","journal-title":"Wien Klin Wochenschr."},{"issue":"1","key":"2019080105002838900_CIT0054","first-page":"e1","article-title":"Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly","volume":"16","author":"Stockl","year":"2010","journal-title":"Am J Manag Care."},{"issue":"3","key":"2019080105002838900_CIT0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/02813432.2012.704813","article-title":"Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards","volume":"30","author":"Bakken","year":"2012","journal-title":"Scand J Prim Health Care."},{"issue":"4","key":"2019080105002838900_CIT0056","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.9778\/cmajo.20140027","article-title":"Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis","volume":"2","author":"Gomes","year":"2014","journal-title":"CMAJ Open."},{"issue":"3","key":"2019080105002838900_CIT0057","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1521-0391.2014.12091.x","article-title":"High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study","volume":"23","author":"Nosyk","year":"2014","journal-title":"Am J Addict."},{"issue":"2","key":"2019080105002838900_CIT0058","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jppr199828283","article-title":"Patterns of analgesic prescribing for patients with chronic non-malignant pain in NSW","volume":"28","author":"Bramley-Moore","year":"1998","journal-title":"Aust J Hosp Pharm."},{"issue":"1","key":"2019080105002838900_CIT0059","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pain.2010.04.012","article-title":"The course of opioid prescribing for a new episode of disabling low back pain: opioid features and dose escalation","volume":"151","author":"Cifuentes","year":"2010","journal-title":"Pain."},{"issue":"5","key":"2019080105002838900_CIT0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1090-3801(02)00148-9","article-title":"Transdermal fentanyl: informed prescribing is essential","volume":"7","author":"Ross","year":"2003","journal-title":"Eur J Pain."},{"issue":"2","key":"2019080105002838900_CIT0061","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pds.2164","article-title":"Utilisation of transdermal fentanyl in Germany from 2004 to 2006","volume":"21","author":"Garbe","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"4","key":"2019080105002838900_CIT0062","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpainsymman.2008.11.008","article-title":"Frequency of long-acting opioid analgesic initiation in opioid-na\u00efve nursing home residents","volume":"38","author":"Dosa","year":"2009","journal-title":"J Pain Symptom Manage."},{"issue":"6","key":"2019080105002838900_CIT0063","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2710.2005.00690.x","article-title":"Opioid prescribing: an assessment using quality statements","volume":"30","author":"Jenkins","year":"2005","journal-title":"J Clin Pharm Ther."},{"issue":"5","key":"2019080105002838900_CIT0064","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pds.2250","article-title":"How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?","volume":"21","author":"Richarz","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"2019080105002838900_CIT0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/dar.12541","article-title":"Addressing the prescription opioid crisis: potential for hospital-based interventions?","volume":"36","author":"Kim","year":"2017","journal-title":"Drug Alcohol Rev."},{"issue":"16","key":"2019080105002838900_CIT0066","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2013.280377","article-title":"Physician education in addiction medicine","volume":"310","author":"Wood","year":"2013","journal-title":"JAMA."},{"issue":"12","key":"2019080105002838900_CIT0067","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jpain.2011.06.006","article-title":"Pain education in North American medical schools","volume":"12","author":"Mezei","year":"2011","journal-title":"J Pain."},{"key":"2019080105002838900_CIT0068","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2016.04.002","article-title":"Physician continuing education to reduce opioid misuse, abuse, and overdose: many opportunities, few requirements","volume":"163","author":"Davis","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"2019080105002838900_CIT0069","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.4103\/2152-7806.139612","article-title":"Multidisciplinary in-hospital teams improve patient outcomes: a review","volume":"5","author":"Epstein","year":"2014","journal-title":"Surg Neurol Int."},{"issue":"23","key":"2019080105002838900_CIT0070","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2146\/ajhp120751","article-title":"Implementation of a pain medication stewardship program","volume":"70","author":"Ghafoor","year":"2013","journal-title":"Am J Health-Syst Pharm."},{"issue":"2","key":"2019080105002838900_CIT0071","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajic.2012.02.021","article-title":"Clinical and economic outcomes from a community hospital\u2019s antimicrobial stewardship program","volume":"41","author":"Malani","year":"2013","journal-title":"Am J Infect Control."},{"issue":"17","key":"2019080105002838900_CIT0072","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2146\/ajhp110603","article-title":"Clinical and economic outcomes of a prospective antimicrobial stewardship program","volume":"69","author":"Nowak","year":"2012","journal-title":"Am J Health Syst Pharm."},{"key":"2019080105002838900_CIT0073","first-page":"6","article-title":"Opioids for pain optimized by stewardship plan: major savings reported","volume":"42","author":"Wild","year":"2015","journal-title":"Pharm Pract News."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxz092\/28882609\/zxz092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/16\/1231\/29026132\/zxz092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T09:54:38Z","timestamp":1663840478000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/16\/1231\/5525025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":73,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2019,6,28]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxz092","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8,15]]},"published":{"date-parts":[[2019,6,28]]}}}